Titan Pharmaceuticals, Inc. Deferred Income, Current
Titan Pharmaceuticals, Inc. had Deferred Income, Current of $119.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredIncomeCurrent · last filed 2020-11-16
- 2020-09-30: Deferred Income, Current $119.00K.
- 2020-06-30: Deferred Income, Current $64.00K.
- 2020-03-31: Deferred Income, Current $201.00K.
- 2019-12-31: Deferred Income, Current $809.00K.
| Period end | Deferred Income, Current |
|---|---|
| 2020-09-30 | $119.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $64.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $201.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $809.00K 10-Q · filed 2020-11-16 |
| 2019-09-30 | $750.00K 10-Q · filed 2019-11-14 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |